Join
Live feed
·
INSIDERFilingvia Quantisnow
Silo Pharma Inc. logo

Chief Executive Officer Weisblum Eric bought $4,847 worth of shares (12,000 units at $0.40), increasing direct ownership by 6% to 209,932 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SILO· Silo Pharma Inc.
Consumer Discretionary
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SILO (Silo Pharma Inc.) and more on Quantisnow.